The expanding universe of type I regulatory T cell biology: a new role in cancer immunotherapy.
Immunol Cell Biol
; 2024 Sep 11.
Article
de En
| MEDLINE
| ID: mdl-39261289
ABSTRACT
In this article, we discuss new findings which suggest that type I regulatory T (Tr1) cells can interfere with cancer vaccine efficacy in mice by exerting strong regulatory control over antitumor immune responses.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
Immunol Cell Biol
Sujet du journal:
ALERGIA E IMUNOLOGIA
Année:
2024
Type de document:
Article
Pays d'affiliation:
États-Unis d'Amérique
Pays de publication:
États-Unis d'Amérique